Advancements in cellular therapies, biomaterials, and gene-editing tools are transforming how the body’s own repair mechanisms are harnessed. By integrating cutting-edge approaches like CRISPR, stem cell transplantation, and scaffold-based tissue repair, scientists are closing the gap between damage and recovery. Within this dynamic field, regenerative medicine continues to evolve as a solution to chronic diseases and organ failure, replacing traditional methods that focus solely on symptom management. Researchers are now exploring how biological cues and microenvironment modulation can guide tissue regrowth more effectively. Clinical pipelines are expanding rapidly with new trials targeting cartilage regeneration, myocardial repair, and even neural tissue restoration. The potential of regenerative medicine is no longer confined to theoretical constructs—it is being translated into viable therapies with measurable patient outcomes.
Title : AI-integrated high-throughput tissue-chip for space-based biomanufacturing applications
Kunal Mitra, Florida Tech, United States
Title : Will be updated soon...
Vasiliki E Kalodimou, European University-Cyprus Ltd, Cyprus
Title : Will be updated soon...
Nagy Habib, Imperial College London, United Kingdom
Title : Will be updated soon...
Alexander Seifalian, Nanotechnology & Regenerative Medicine Commercialisation Centre, United Kingdom
Title : Advanced 3D tissue models: Pioneering tools for investigating health and disease
Lucie Bacakova, Institute of Physiology of the Czech Academy of Sciences, Czech Republic
Title : Developing iPSC-derived 3D Outer Blood-Retinal Barrier Disease Models of Choroideremia for Gene Therapy Evaluation
Aradhana Kasimsetty, National Center for Advancing Translational Sciences (NCATS), National Institutes of Health (NIH), United States